Your download is now in progress and you may close this window

Did you know that with a free Taylor & Francis Online account you can gain access to the following benefits?

Choose new content alerts to be informed about new research of interest to you
Easy remote access to your institution's subscriptions on any device, from any location
Save your searches and schedule alerts to send you new results
Export your search results into a .csv file to support your research

Have an account?
Login now Don't have an account?
Register for free

Login or register to access this feature

Have an account?
Login now Don't have an account?
Register for free

Choose new content alerts to be informed about new research of interest to you
Easy remote access to your institution's subscriptions on any device, from any location
Save your searches and schedule alerts to send you new results
Export your search results into a .csv file to support your research

Search in:

Advanced search

Journal of Medical Economics Volume 25, 2022 - Issue 1

Submit an article Journal homepage

Open access

3,251

Views

CrossRef citations to date

Altmetric

Oncology

Cost-effectiveness of brentuximab vedotin for relapsed or refractory systemic anaplastic large-cell lymphoma in China

Jia Liua School of Pharmaceutical Science and Technology, Tianjin University, Tianjin, China;b Center for Social Science Survey and Data, Tianjin University, Tianjin, China

Lei Zhengc Takeda China, Shanghai, China

Ling-Hsiang Chuangd Umea University, Umea, Sweden;e GongJing Healthcare, Nanjing, ChinaCorrespondence[email protected]

Pages 99-107 | Received 18 May 2021, Accepted 16 Dec 2021, Published online: 12 Jan 2022

Cite this article
https://doi.org/10.1080/13696998.2021.2020567
CrossMark

Full Article
Figures & data
References
Citations
Metrics
Licensing
Reprints & Permissions
View PDF PDF View EPUB EPUB

Citations (3)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Articles from other publishers (3)

Chunmeng Wang, Yuting Pan, Yang Liu, Bing Guo, Jinhong Shi, Guanghua Rong, Zhipeng Guo, Zhifang Li, Qingming Yang, Jing Nie & Weidong Han. (2023) Long‐term complete remission and peripheral biomarkers in Hodgkin lymphoma patients after decitabine‐plus‐camrelizumab epi‐immunotherapy and treatment cessation. MedComm 4:6.
Crossref

Xudong Zhang, Honghan Qiao, Xiaofei Chai, Xue Gao, Rongjun Ma, Yufu Li, Zunmin Zhu & Mingzhi Zhang. (2023) Brentuximab vedotin in treating Chinese patients with lymphoma: A multicenter, real‐world study. Cancer Medicine 12:24, pages 21725-21734.
Crossref

Junjun Wu, Xiaoyan Lan, Zhenling Liao, Jingyi Chen, Yong Wu & Rong Hu. (2023) Comparison of the sense of spousal support, anxiety, depression and their relationship to fear of cancer recurrence between lymphoma patients and their spouses: A cross-sectional study in China. Journal of Cancer Survivorship.
Crossref

Share icon
Back to Top

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references